Cat. #152144
Anti-Nampt [14A5]
Cat. #: 152144
Sub-type: Primary antibody
Target: Nicotinamide phosphoribosyl transferase (NAMPT)
Class: Monoclonal
Application: ELISA ; IHC ; IP ; WB ; enzymatic activity inhibition
Reactivity: Human ; Mouse
Host: Rat
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Anthony Rongvaux, Fabienne Andris
Institute: Free University of Brussels
Primary Citation: Rongvaux et al. 2002. Eur J Immunol. 32(11):3225-34. PMID: 12555668.
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-Nampt [14A5]
- Research fields: Cancer;Cell signaling and signal transduction;Immunology;Metabolism;Neurobiology;Tissue-specific biology
- Clone: 14A5
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 52 kDa
- Reactivity: Human ; Mouse
- Host: Rat
- Application: ELISA ; IHC ; IP ; WB ; enzymatic activity inhibition
- Description: Nicotinamide phosphoribosyltransferase (NAMPT) is a member of the NAPRTase family. Its primary role is to catalyze the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD.
- Immunogen: Recombinant mouse Nampt
- Isotype: IgG2a kappa
Target Details
- Target: Nicotinamide phosphoribosyl transferase (NAMPT)
- Molecular weight: 52 kDa
- Target background: Nicotinamide phosphoribosyltransferase (NAMPT) is a member of the NAPRTase family. Its primary role is to catalyze the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD.
Applications
- Application: ELISA ; IHC ; IP ; WB ; enzymatic activity inhibition
Handling
- Shipping conditions: Shipping at 4° C
References
- Rongvaux et al. 2002. Eur J Immunol. 32(11):3225-34. PMID: 12555668.
